Okumura Tomoyuki, Tsunoda Shigeru, Mori Yukiko, Ito Tetsuo, Kikuchi Keiji, Wang Timothy Cragin, Yasumoto Shigeru, Shimada Yutaka
Department of Surgery and Surgical Basic Science, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Clin Cancer Res. 2006 Sep 1;12(17):5096-103. doi: 10.1158/1078-0432.CCR-05-2852.
In this study, we investigated the clinicopathologic significance of the low-affinity p75 neurotrophin receptor (p75NTR; which is expressed in the stem/progenitor cell fraction of normal esophageal epithelial cells) in 187 resected esophageal squamous cell carcinoma (ESCC) specimens and found that approximately 50% of ESCC expressed p75NTR. Our investigation using ESCC cell lines showed that p75NTR was intensely expressed in the cells with high colony-forming capacity but they were sensitive to cell death on inhibition of p75NTR expression with transient transfection of small interfering RNA (siRNA). These findings suggest that p75NTR is necessary for survival and maintenance of ESCC tumors, providing us with a potential target for novel therapies.
p75NTR is expressed in a stem/progenitor cell fraction of human normal esophageal epithelial cells. In this study, we investigated the expression and biological role of p75NTR in ESCC.
The expression of p75NTR in 187 resected ESCC specimens was immunohistochemically investigated. The expression of p75NTR in 30 ESCC cell lines (KYSEs) was assessed by reverse transcription-PCR, immunocytochemistry, and flow cytometry. The p75NTR-bright and p75NTR-dim/negative cells were isolated from KYSE150 by magnetic beads and colony formation was investigated. The role of p75NTR in KYSEs was assessed by transient transfection of siRNA.
p75NTR was expressed in 92 of 187 (49.2%) tumors. In well-differentiated tumors, positive staining was apparent in the first one to two layers from infiltrative margin of the tumors where most of the cells were actively proliferating. In moderately differentiated tumors, p75NTR was expressed in wider range from the margin of the tumors whereas p75NTR was diffusely distributed in poorly differentiated tumors. p75NTR was expressed in all examined KYSEs and the mean proportion of the p75NTR-bright fraction was 30.1%. The size of p75NTR-positive colonies was larger than that of p75NTR-negative colonies derived from KYSE150 (P<0.0001). The purified p75NTR-bright cells formed p75NTR-positive large colonies more frequently than the p75NTR-dim/negative cells (P<0.0001). Down-regulation of p75NTR expression by siRNA resulted in marked growth inhibition with induction of apoptosis.
Our findings suggest that p75NTR is necessary for survival and maintenance of ESCC tumors, providing us with a potential target for novel therapies.
在本研究中,我们调查了低亲和力p75神经营养因子受体(p75NTR;在正常食管上皮细胞的干细胞/祖细胞部分表达)在187例切除的食管鳞状细胞癌(ESCC)标本中的临床病理意义,发现约50%的ESCC表达p75NTR。我们使用ESCC细胞系进行的研究表明,p75NTR在具有高集落形成能力的细胞中强烈表达,但在用小干扰RNA(siRNA)瞬时转染抑制p75NTR表达时,它们对细胞死亡敏感。这些发现表明,p75NTR是ESCC肿瘤存活和维持所必需的,为我们提供了一种新的治疗潜在靶点。
p75NTR在人正常食管上皮细胞的干细胞/祖细胞部分表达。在本研究中,我们调查了p75NTR在ESCC中的表达及生物学作用。
免疫组织化学研究187例切除的ESCC标本中p75NTR的表达。通过逆转录聚合酶链反应、免疫细胞化学和流式细胞术评估30个ESCC细胞系(KYSEs)中p75NTR的表达。通过磁珠从KYSE150中分离出pI75NTR高表达和p75NTR低表达/阴性细胞,并研究集落形成。通过siRNA瞬时转染评估p75NTR在KYSEs中的作用。
187例肿瘤中有92例(49.2%)表达p75NTR。在高分化肿瘤中,从肿瘤浸润边缘的前一到两层可见阳性染色,其中大多数细胞处于活跃增殖状态。在中分化肿瘤中,p75NTR从肿瘤边缘开始在更广泛的范围内表达,而在低分化肿瘤中p75NTR呈弥漫分布。所有检测的KYSEs均表达p75NTR,p75NTR高表达部分的平均比例为30.1%。KYSE150来源的p75NTR阳性集落的大小大于p75NTR阴性集落(P<0.0001)。纯化的p75NTR高表达细胞比p75NTR低表达/阴性细胞更频繁地形成p75NTR阳性大集落(P<0.0001)。siRNA下调p75NTR表达导致明显的生长抑制并诱导细胞凋亡。
我们的发现表明,p75NTR是ESCC肿瘤存活和维持所必需的,为我们提供了一种新的治疗潜在靶点。